Promisia Healthcare Limited logo

Issue of shares

Capital Raise4 November 2019PHLHealthcare

Promisia Ltd
22 Panama St,

Wellington,

New Zealand 6011


DDI +64 4 499 5563

Mobile +64 21 571 000

E rene@promisia.com


PROMISIA.COM


ANNOUNCEMENT

4 November 2019

NZSX/NZDX

NOTICE PURSUANT TO LISTING RULE 7.12.1


(a) Class of Security and ISIN: Ordinary Shares (PIL)NZPRE0001S5

(b) Number issued/acquired: 250,000,000

(c) Issue/Acquisition price: $.001 per share

(d) Payment in Cash: Yes

(e) Amount paid up: Fully Paid

(f) Percentage total of class of securities: 11.62%

(g) Reason for issue/acquisition: Exercise of option to acquire shares to

provide working capital

(h) Specific authority for issue/acquisition: Resolution of shareholders at a special

meeting of shareholders held 4

December 2018

(i) Any terms or details of the

issue/acquisition:

N/A

(j) Total number of securities on issue

after issue/acquisition:

2,151,797,451

(k) Companies Act 1993 registered

company – shares to be held as

Treasury Stock:

No

(l) Date of issue/acquisition: 4/11/2019


Stephen Underwood


Chairman – Promisia Integrative Limited

---

Promisia Ltd
22 Panama St,

Wellington,

New Zealand 6011


DDI +64 4 499 5563

Mobile +64 21 571 000

E rene@promisia.com


PROMISIA.COM



4 November 2019

Issue of Shares following payment in full on exercise of an option to subscribe for shares

The directors of Promisia Integrative Limited advise that a total of 250,000,000 new shares have

been issued by the company today to the Brankin Trust following the completion of payments to

exercise an option to subscribe for shares.

This transaction was approved by shareholders on 4 December 2018 and the decision by Brankin

Trust to exercise its option was advised to the market on 22 January 2019. Brankin Trust has made

progressive payments to the company over the last 10 months and the sum of $250,000 is now paid

in full and the shares can be issued as fully paid.

The directors thank the Brankin Trust for its support and the provision of funding as the company

awaits resolution of its prosecution by the Ministry of Health.

Please find the Allotment Notice pursuant to Listing Rule 7.12.1 attached.


Stephen Underwood 027 499 3387

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.